A problem in diagnosing N3 disease using FDG-PET in patients with lung cancer: High false positive rate with visual assessment

Annals of Nuclear Medicine

Volumn 18, Issue 6, 2004, Pages 483-488

  Hara, Masaki ^a   Shiraki, Norio ^a   Itoh, Masato ^a   Shibamoto, Yuta ^a   Iida, Akihiko ^b   Nishio, Masami ^c   Tamaki, Tsuneo ^c  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya City Rehabilitation and Sports Center Hospital   (Japan)

^c Nagoya Kyoritu Hospital   (Japan)

Author keywords

False positive; FDG PET; Lung cancer; N3; Nodal staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG UPTAKE; FEMALE; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 6944247402     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984564     Document Type: Article

References (20)

1. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RJ, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion image: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
2. 18FDG in patients with bronchogenic carcinoma. Chest 1995; 108: 1617-1621.
3. Scott WJ, Gobar LS, Terry JD, Dewen NA, Sunderland JJ, Little AG. Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996; 111: 642-648.
4. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, et al. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202: 441-446.
5. 18F]FDG positron emission tomography (PET). Thorax 1997; 52: 438-441.
6. Boiselle PM, Patz EF Jr, Vining DJ, Weissleder R, Shephard JA, McLoud TC. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics 1998; 18: 1061-1069.
7. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212: 803-809.
8. Ahuja V, Coleman RE, Herndon J, Patz EF Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma. Cancer 1998; 83: 918-924.
9. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics 1999; 19: 61-77.
10. Bakheet SM, Sleem M, Powe J, Al Amro A, Larsson SG, Mahassin Z. F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection. Clin Nucl Med 2000; 25: 273-278.
11. Inoue K, Matoba S. Counterattack of re-emerging tuberculosis after 38 years. Int J Tuberc Lung Dis 2001; 5: 873-875.
12. Fujimoto K, Edamitsu O, Meno S, Abe T, Honda N, Ogoh Y, et al. MR diagnosis for metastasis or non-metastasis of mediastinal and hilar lymph nodes in case of primary lung cancer: Detectability, signal intensity, and MR-pathologic correlation. Nippon Igaku Hoshasen Gakkai Zasshi 1995; 55: 162-171.
13. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: 2142-2419.
14. Liewald F, Grosse S, Storck M, Guhlmann A, Halter G, Reske S, et al. How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer? Thorac Cardiovasc Surg 2000; 48: 93-96.
15. Yoon YC, Lee KS, Shim YM, Kim B-T, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection - prospective study. Radiology 2003; 227: 764-770.
16. Fujii H, Yasuda S, Ide M, Takahashi W, Mochizuki Y, Shohtsu A, et al. Hilar activity on the F-18 FDG whole-body PET studies. Jpn J Clin Radiol 1999; 44: 199-206.
17. Shiraki N, Hara M, Ogino H, Shibamoto Y, Iida A, Tamaki T, et al. False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET-Radiological-pathological correlation-. Ann Nucl Med 2004; 18: 23-28.
18. Lowe VJ, Duhaylongsod FG, Patz EF Jr, Delong DM, Hoffman JM, Wolfe WG, et al. Pulmonary abnormalities and PET data analysis: A retrospective study. Radiology 1997; 202: 435-439.
19. Farrell MA, McAdams HP, Herndorn JE, Patz EF Jr. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000; 215: 886-890.
20. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.